James M. Roach

James M. Roach

Teknisk/Vetenskaplig/F&U Direktör på CLEMENTIA PHARMACEUTICALS INC
66 år
Health Technology
Consumer Services

Profil

James M.
Roach
currently works at Clementia Pharmaceuticals, Inc., as Executive Vice-President-Research & Development.
Dr. Roach also formerly worked at Sumitomo Pharma America, Inc., as Senior Vice President-Medical Affairs from 2002 to 2008, Millennium Pharmaceuticals, Inc., as Head-Medical Affairs & Clinical Research, LeukoSite, Inc., as Head-Medical Affairs, Momenta Pharmaceuticals, Inc., as Chief Medical Officer & Senior VP-Development from 2011 to 2016, Astra USA, Inc., as Head-Medical Affairs, Harvard Medical School, as Assistant Clinical Professor, Veristat LLC, as Chief Medical Officer, and Pulmatrix, Inc., as Chief Medical Officer from 2017 to 2019.
Dr. Roach received his undergraduate degree from College of the Holy Cross (Massachusetts) and doctorate degree from Georgetown University School of Medicine.

Aktiva positioner av James M. Roach

FöretagPositionStart
CLEMENTIA PHARMACEUTICALS INC Teknisk/Vetenskaplig/F&U Direktör -

Tidigare kända positioner av James M. Roach

FöretagPositionSlut
PULMATRIX, INC. Teknisk/Vetenskaplig/F&U Direktör 2019-03-08
MOMENTA PHARMACEUTICALS, INC. Teknisk/Vetenskaplig/F&U Direktör 2016-11-29
Teknisk/Vetenskaplig/F&U Direktör 2008-02-01
Astra USA, Inc.
Teknisk/Vetenskaplig/F&U Direktör -
Teknisk/Vetenskaplig/F&U Direktör -
Se detaljerna i James M. Roachs erfarenhet

James M. Roachs utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

53

Första gradens relationer

11

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Astra USA, Inc.

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. James M. Roach
SENASTE TIDEN | -40%: De bästa verktygen för prenumeranter för att identifiera morgondagens bästa investeringar!
d
:
:
TA FÖRDEL AV DET NU